Condition
Presbyvestibulopathy
Total Trials
4
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Recruiting3
Withdrawn1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07709143Recruiting
MRI Performance and Risk Factors in Bilateral Vestibular Hypofunction
NCT06732440Not ApplicableRecruiting
Subthreshold Vestibular Stimulation as a Strategy for Rehabilitation
NCT05676944Not ApplicableRecruiting
Vestibular Implantation in Older Adults
NCT05932979Phase 2WithdrawnPrimary
Effect of the Administration of L-arginine vs. Placebo in Patients Diagnosed With Presbyvestibulopathy.
Showing all 4 trials